Mei Baisong sold EDIT

March 4, 2024 · Form 4 insider transaction

Mei Baisong sold 20,327 shares of Editas Medicine, Inc. at $9.42 per share, a transaction worth $191.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
20,327
Price
$9.42
Total value
$191.4K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2024
Filing dateMarch 5, 2024
Shares owned after141,543
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.; This transaction was executed in multiple trades at prices ranging from $9.1036 to $9.4298. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR